rs140192373
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001723.7(DST):c.7135G>A(p.Ala2379Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00151 in 1,613,714 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001723.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DST | NM_001723.7 | c.7135G>A | p.Ala2379Thr | missense_variant | 24/24 | ENST00000370765.11 | NP_001714.1 | |
DST | NM_001374736.1 | c.4930-1848G>A | intron_variant | ENST00000680361.1 | NP_001361665.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DST | ENST00000370765.11 | c.7135G>A | p.Ala2379Thr | missense_variant | 24/24 | 1 | NM_001723.7 | ENSP00000359801.6 | ||
DST | ENST00000680361.1 | c.4930-1848G>A | intron_variant | NM_001374736.1 | ENSP00000505098.1 |
Frequencies
GnomAD3 genomes AF: 0.00141 AC: 215AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00217 AC: 543AN: 250570Hom.: 1 AF XY: 0.00246 AC XY: 333AN XY: 135500
GnomAD4 exome AF: 0.00152 AC: 2217AN: 1461430Hom.: 4 Cov.: 34 AF XY: 0.00167 AC XY: 1213AN XY: 727046
GnomAD4 genome AF: 0.00141 AC: 215AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.00137 AC XY: 102AN XY: 74472
ClinVar
Submissions by phenotype
not provided Benign:6
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | DST: BP4, BS1 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 03, 2021 | - - |
Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
DST-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 08, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at